INCY vs ITRM · P/E 14, rev $5.14B vs rev $390.0K
Incyte Corporation (INCY) versus Iterum Therapeutics PLC (ITRM) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. ITRM currently screens at market cap $38.6M.
Not investment advice. Open the INCY and ITRM stock pages for the full models.
Not investment advice.